PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 59 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $114,625,000 | -38.7% | 5,827,415 | 0.0% | 8.82% | -41.0% |
| Q3 2021 | $187,060,000 | -5.2% | 5,827,415 | 0.0% | 14.97% | -17.7% |
| Q2 2021 | $197,258,000 | -9.9% | 5,827,415 | 0.0% | 18.19% | +3.6% |
| Q1 2021 | $218,878,000 | +13.1% | 5,827,415 | 0.0% | 17.56% | +17.8% |
| Q4 2020 | $193,587,000 | -9.4% | 5,827,415 | 0.0% | 14.91% | -22.3% |
| Q3 2020 | $213,691,000 | +11.4% | 5,827,415 | 0.0% | 19.18% | +13.9% |
| Q2 2020 | $191,780,000 | +2.0% | 5,827,415 | -20.0% | 16.84% | -21.0% |
| Q1 2020 | $188,080,000 | -17.1% | 7,284,269 | 0.0% | 21.32% | -43.9% |
| Q4 2019 | $226,832,000 | – | 7,284,269 | – | 38.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |